Medindia

X

/K I L L K I L L K I L L -- Pacali Consulting Group/

Friday, August 22, 2008 General News J E 4
Advertisement
We are advised by Pacali Consulting Group that journalists and otherreaders should disregard the news release, Restylane or Juvederm: Two RivalsGo to the Mats in the Never Ending Battle of the Wrinkle Remover Competition,issued earlier today over PR Newswire, as it was issued without authorization.

SOURCE Pacali Consulting Group
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Biopure Announces 2008 Third Quarter Financial Res...
S
Telik's Proteasome Inhibitor Program Meets a Precl...